SCHEMBL1822104

SCHEMBL1822104

CSc1cc(-c2cncnc2O)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13898065 0.82 CYP17A1 (0.37)
SCHEMBL1819804 0.81 CDC25B (0.31)
SCHEMBL12311621 0.75
SCHEMBL2762738 0.67 MAPT (0.33)
SCHEMBL12264212 0.67 FGFR3 (0.43)
SCHEMBL3583029 0.67 GAA (0.40)
SCHEMBL3582094 0.66 PI4KA (0.38)
SCHEMBL10933998 0.65
SCHEMBL24623012 0.64 PIP4K2A (0.43)
SCHEMBL6747447 0.63 ASIC3 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026243-B2 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors NOVARTIS AG (CH) 2011-09-27 US disclosed
US-8026243-B2 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors NOVARTIS AG (CH) 2011-09-27 US disclosed
US-8026243-B2 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors NOVARTIS AG (CH) 2011-09-27 US disclosed
EP-2044036-B1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2011-05-04 EP disclosed
EP-2044036-B1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2011-05-04 EP disclosed
US-20100234376-A1 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors NOVARTIS AG 2010-09-16 US disclosed
US-20100234376-A1 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors NOVARTIS AG 2010-09-16 US disclosed
US-20100234376-A1 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors NOVARTIS AG 2010-09-16 US disclosed
EP-2044036-A1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM, LLC (BM) 2009-04-08 EP disclosed
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-03-12 US disclosed
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-03-12 US disclosed
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-03-12 US disclosed
EP-1981870-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-10-22 EP disclosed
WO-2008008747-A1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2008-01-17 WO disclosed
WO-2007092531-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2007-08-16 WO disclosed
WO-2007092531-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2007-08-16 WO disclosed